Skip to main content

B-SMART PC Biologic and Social Modifiers of Aggressiveness and Risk in Tumors

Research Topic: Prostate Cancer

Study Title: B-SMART PC Biologic and Social Modifiers of Aggressiveness and Risk in Tumors

Research Team:
Matthew Cooperberg, MD, MPH, Principal Investigator (PI)
Kiana Washington, Clinical Research Coordinator

Sponsor: National Cancer Institute (NCI)

Who can join?

Green check mark
  • Age range: 18+ 
  • This study is open to men who are Black, Hispanic/Latino, and Asian.
  • Participants must be individuals who have been diagnosed with prostate cancer and have either undergone or are scheduled to undergo a radical prostatectomy. 

What to Expect During the Study

Image
clipboard
Research activities

Participants will take part in two remote surveys.

Image
Globe
Location

In person and remote

UCSF Mission Bay
San Francisco VA Medical Center (SFVA)
Santa Clara Valley Hospital
Highland Hospital

Image
Stick figures in a circle
How you can help
  • Participation in this study will help advance research to develop more personalized prevention strategies and improve future approaches to prostate cancer care. 
  • Participation will support efforts to reduce disparities and improve outcomes for future patients.

FAQ's

This study consists of a single participation period with two brief online surveys completed at different times. Overall participation is short-term and can be completed in approximately 120 minutes.

Eligible individuals will receive an invitation email to learn more about the study, with a friendly follow-up phone call one week later if needed. Those who choose to participate will review and sign an electronic consent form, complete two brief online surveys, and receive a thank-you email along with a $50 e-gift card in appreciation of their time.

Yes, the monetary compensation for the whole study is $50.

We are planning to enroll 300 participants. 100 Black men, 100 Hispanic/Latino men, and 100 Asian men.

Contact us

Kiana Washington, Clinical Research Coordinator
[email protected]
(415) 514-8026